Pathogenesis of ovarian seromucinous borderline tumors

Mekan R. Orazov , Marina V. Kiseleva , Vladlena M. Pernay

For citation:

Abstract

he 2014 World Health Organization classification identifies ovarian seromucinous tumors as one of the six categories of epithelial ovarian tumors. Ovarian seromucinous tumors encompass adenomas, atypical proliferating (borderline) tumors, and invasive carcinomas. These tumors are exceedingly rare, with benign instances accounting for a mere 1% and 25% of borderline cases among all atypical proliferating tumors. The rarity of seromucinous cancer means its prevalence has not been thoroughly investigated, which has resulted in this group of tumors remaining incompletely researched.

Keywords: ovarian seromucinous borderline tumors, endometriosis, treatment, histogenesis.

References

1. Ершов В.А., Михайлов В.М., Чирский В.С. Резервные и базальные клетки эпителия шейки матки как источник цервикальных неоплазий, ассоциированных с вирусами папилломы человека. Гены и клетки. 2019;14(1):80-4. Ershov V.A., Mikhailov V.M., Chirsky V.S. Reserve and basal cells of the cervical epithelium as a source of cervical neoplasia associated with human papillomaviruses. Genes and cells. 2019;14(1):80-4. (in Russian).

2. Guan B, Wang TL, Shih IeM. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 2012;72(12):3116

3. Fox H, Langley FA. Tumors of the ovary. William Heinemann/Year Book, 1976.

4. Karpathiou G, Chauleur C, Corsini T et al. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. Ann Diagn Pathol 2017;27:28-33.

5. Karpathiou G, Chauleur C, Venet M et al. Pathology of the fallopian tube: tubal involvement by ovarian tumors and incidental findings in the nontumoral setting. Pathobiology 20200;87(1):37-44.

6. Kurman RJ, Shih IeM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol 2016.

7. Hada T, Miyamoto M, Ishibashi H et al. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline. Tumors In Vivo 2020.

8. Jones S, Wang TL, Shih IeM et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010.

9. Nagayoshi Y, Yamada K, Kiyokawa T et al. Clinical Features of Borderline Ovarian Seromucinous Tumor. Cancer Diagn Progn 2023.

10. Vroobel K, McCluggage M, Glenn W. Ovarian Clear Cell Tumors Associated With Seromucinous Borderline Tumor: A Case Series. Int J Gynecol Pathol 2022.

11. Wu B, Li J, Tao X et al. Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study. Reprod Sci 2023.

12. Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis. Cancer 1988.

13. Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 1988.

14. Wiegand KC, Shah SP, Al-Agha OM et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010.

15. Wilsker D, Probst L, Wain HM et al. Nomenclature of the ARID family of DNA-binding proteins. Genomics 2005.

16. Wu CH, Mao TL, Vang R et al. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 2012.

17. Wu RC, Chen SJ, Chen HC et al. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor. Mod Pathol 2020.

18. Ng A, Barker N. Ovary and fimbrial stem cells: biology, niche and cancer origins. Nat Rev Mol Cell Biol 2015.

19. Rambau PF, McIntyre JB, Taylor J et al. Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary. Am J Surg Pathol 2017.

20. Новиков Ф.В., Лунева И.С., Мишина Е.С., Мнихович М.В. Морфологические основы гистогенеза опухолей яичника. Опухоли женской репродуктивной системы. 2020. Novikov F.V., Luneva I.S., Mishina E.S., Mnikhovich M.V. Morphological basis of the histogenesis of ovarian tumors. Tumors of the female reproductive system. 2020 (in Russian).

21. Nagamine M, Mikami Y. Ovarian seromucinous tumors: pathogenesis, morphologic spectrum, and clinical issues. Diagnostics (Basel) 2020; 10.

22. Tavassoli F, Devilee P. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon, 2003.

23. Hu, Y, Fu K, Liu H et al. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer? J Ovarian Res 2023;16(1). DOI: 10.1186/s13048-023-01100-w

For citation:Orazov M.R., Kiseleva M.V., Pernay V.M. Pathogenesis of ovarian seromucinous borderline tumors. Clinical analysis in general medicine. 2024; 5 (7): 74–82. (In Russ.). DOI: 10.47407/kr2024.5.7.00p425

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice